|
|
 | | | |
- close
- close
- close
- close
QUOTE AND NEWS
Benzinga
Apr 25
Comment
Jefferies increases its price target from $18.50 to $24 on Hold-rated ICON (NASDAQ: ICLR) following solid results, but reiterates Hold on shares as it sees no need to chase the stock currently.
Jefferies notes, "ICLR's strong bookings are...
Business Wire
Apr 24
Comment
ICON (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2012. For the
Market Intelligence Center
Apr 17
Comment
ICON Plc (NASDAQ:ICLR) closed Monday's reticent trading session at $20.85. In the past year, the stock has hit a 52-week low of $15.03 and 52-week high of $26.22. ICON Plc (ICLR) stock has been showing support around $19.88 and resistance in the...
Marketwire
Apr 10
Comment
DUBLIN, IRELAND and NEW YORK, NY -- (Marketwire) -- 04/10/12 -- As more and more R&D is outsourced by pharmaceutical companies, a study released today provides new insight into how to structure the relevant partnerships for success. ICON plc (NASDAQ:
StreetInsider.com
Mar 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/ICON+plc+%28ICLR%29+Becomes+Roche+%28RHHBY%29+Tech+Partner+for+Clinical+Research+Programs/7238093.html for the full story.
Business Wire
Feb 28
Comment
ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PriceSpective LLC, a global leader in value
Benzinga
Feb 17
Comment
Jefferies maintains its Hold rating on ICON (NASDAQ: ICLR) and raises its price target to $18.50 from $17 following still-slow revenue conversion, which was expected.
Jefferies says, "ICLR's 1.6% decline on Thursday was directionally correct,...
Benzinga
Feb 15
Comment
According to a research report released today, Sterne Agee has upgraded ICON plc's (NASDAQ: ICLR) stock from Underperform to Neutral.
In the report, Sterne Agee commented, “We expect ICON to report good progress on strategic partnerships,...
Market Intelligence Center
Feb 14
Comment
ICON Plc (NASDAQ:ICLR) closed Monday's bullish trading session at $20.51. In the past year, the stock has hit a 52-week low of $15.03 and 52-week high of $26.22. ICON Plc (ICLR) stock has been showing support around $20.22 and resistance in the...
Market Intelligence Center
Feb 8
Comment
ICON Plc (NASDAQ:ICLR) closed Tuesday's dramatic trading session at $20.46. In the past year, the stock has hit a 52-week low of $15.03 and 52-week high of $26.22. ICON Plc (ICLR) stock has been showing support around $20.12 and resistance in the...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
